Fujifilm Diosynth celebrates expansion in Denmark
March 4, 2021 -- Contract development and manufacturing organization Fujifilm Diosynth Biotechnologies held a ceremony on March 3 to celebrate the large-scale expansion of cell culture capacity at its production facility in Hillerød, Denmark. Read More
Beckman Coulter launches new benchtop cell sorter
March 4, 2021 -- Beckman Coulter Life Sciences has launched its Cytoflex SRT benchtop cell sorter that features expanded laser and color options. Read More
Caribou nabs $115M to advance CRISPR-edited cell therapies
March 3, 2021 -- Caribou Biosciences has completed $115 million in financing to further develop its next-generation CRISPR technology platform and advance its pipeline of allogeneic immune cell therapies for oncology. Read More
AGC Biologics expands Milan manufacturing facilities
March 3, 2021 -- AGC Biologics said its plans to expand its cell and gene therapy center of excellence in Milan to increase and implement viral vector suspension capabilities. Read More
DNA Script to contribute to DARPA's mobile vaccine manufacturing platform
March 2, 2021 -- DNA Script has been selected by GE Research to join a collaboration to develop a rapid response, mobile medical manufacturing platform to enable on-demand production of nucleic acid-based vaccines and therapies. The project is part of a Defense Advanced Research Projects Agency (DARPA) program. Read More
NanoString increases access to spatial molecular imager
March 2, 2021 -- NanoString Technologies has launched a technology access program for its spatial molecular imager. Read More
WuXi AppTec acquires Oxgene, adding to its CGT capabilities
March 2, 2021 -- WuXi AppTec has completed the acquisition of Oxgene, a U.K.-based contract research and development organization that designs and develops scalable gene therapy technologies. The acquisition will allow WuXi to provide its customers with end-to-end support in the creation and development of cell and gene therapies (CGT), according to the company. Read More
Pharmaron expands CGT capabilities in U.K.
March 1, 2021 -- Pharmaron has purchased Allergan Biologics for $118.7 million from AbbVie, expanding its cell and gene therapy (CGT) capabilities in the U.K. Read More
SalioGen closes $20M to finance nonviral gene therapy development
March 1, 2021 -- SalioGen Therapeutics has closed $20 million in financing to advance its exact DNA integration technology platform for nonviral gene therapy. Read More
Veranome unveils complete spatial omics workflow
March 1, 2021 -- Veranome Biosystems has unveiled its complete sample-to-insight high-plex spatial omics workflow enabled by the company's Pisces technology. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter